WebJun 9, 2024 · Drs. Pourhassan and Kelly of CytoDyn to Hold Conference Call to Provide Updates on COVID-19 Phase 2 and 3 Trials, NASH, BLA for HIV and Manufacturing of … WebDr. Pourhassan received an undergraduate degree from Utah State University, a graduate degree from Brigham Young University and a doctorate from the University of Utah. News CytoDyn Inc. CYDY ...
Nader Pourhassan - CYDY / CytoDyn Inc - Insider Trade Report
WebMar 21, 2024 · Detailed price information for Atico Mining Corp (ATY-X) from The Globe and Mail including charting and trades. WebSep 17, 2024 · Pourhassan, who is 57 years old, faced his own struggles before investing in CytoDyn. He filed for personal bankruptcy twice, once in Utah and once in Oregon, and was indicted for falsely representing dreamcatchers he was selling as Indian-made, a case that was later dismissed. inconsistency\u0027s fu
CytoDyn CEO claims Covid-19 drug success, but details suggest it ... - STAT
WebDear Dr. Pourhassan, As a longtime shareholder of CYDY I must confess to a degree of frustration over recent events. I wanted some time to elapse since the latest conference call to gather my thoughts and pose some questions and suggestions. I'm frustrated because it seems as though the company has some self inflicted wounds. WebDec 20, 2024 · Nader Pourhassan, the former CEO of embattled biotech CytoDyn , has been indicted by a federal court grand jury and accused of conspiracy to defraud … WebMar 29, 2024 · VANCOUVER, Washington, Jan. 11, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY ) ("CytoDyn" or the "Company"), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive … incident in scarborough